Panther Fusion GBS Assay Cartridges 96 Tests, Catalog Number: PRD-04484. in vitro diagnostic tes...

FDA Device Recall #Z-0877-2022 — Class II — March 18, 2022

Recall Summary

Recall Number Z-0877-2022
Classification Class II — Moderate risk
Date Initiated March 18, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Hologic, Inc
Location San Diego, CA
Product Type Devices
Quantity 2061

Product Description

Panther Fusion GBS Assay Cartridges 96 Tests, Catalog Number: PRD-04484. in vitro diagnostic test for group b streptococcus.

Reason for Recall

Samples, run on a GBS Assay, that have analyte concentrations that are at or near the limit of detection may produce false negative results.

Distribution Pattern

US: TX, TN, NY, NV, IN, AR, CA, CT, IL, NH, PA, WA, FL, OR, WV, VA, UT, MA, NJ, MI, PR OUS: CA

Lot / Code Information

UDI: 15420045510890, Lot numbers: 274954, 284599, 296991, 300796, 309230, 309353

Other Recalls from Hologic, Inc

Recall # Classification Product Date
Z-1314-2026 Class II Brevera Breast Biopsy System Disposable 9 Gauge... Dec 15, 2025
Z-1093-2026 Class II ThinPrep¿ CytoLyt¿ Solution. Buffered Cell Wash... Dec 12, 2025
Z-1170-2025 Class II Brand Name: Sertera Biopsy Device Product Name... Jan 15, 2025
Z-0328-2025 Class I BioZorb Marker. Radiographic soft tissue marker. Oct 10, 2024
Z-1733-2024 Class I BioZorb Marker-BioZorb 3D Bioabsorbable Marker-... Mar 13, 2024

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.